Bharat Biotech to launch Covaxin in Q2 2021

Bharat Biotech to launch Covaxin in Q2 2021 The company's vaccine candidate -Covaxin- has been developed in collaboration with the Indian Council of Medical Research (ICMR) - National Institute of Virology (NIV) using inactivated Sars-Cov-2, the virus that causes Covid-19. https://ift.tt/eA8V8J